Clinical Trial Update: BE STUDY OF METFORMIN GSK 1000mg [Phase 2]

View source ↗

Summary

Phase 2 study of Metformin GSK 100 mg for diabetic foot has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot

Drugs mentioned

• Metformin GSK 1000mg (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetic Foot | Phase 2 | Status: COMPLETED